ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 635922 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 635922; 2) Community: the network communities that were significantly associated with the response to NSC 635922; 3) Molecule: the relationships between components within communities and NSC 635922; 4) MDR: the compounds that were significantly associated with the NSC 635922.

NSC Compound Enrichment Correlation
NSC 100046 Elephantopin 0.00662388971299133 0.29826588
NSC 111533 Methoxycamptothecin 0.00662388971299133 0.26360632
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.00662388971299133 0.42903302
NSC 113951 6-Bromotoyocamycin 0.00662388971299133 0.49911881
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.00662388971299133 0.49242695
NSC 135371 Null 0.00662388971299133 0.52846927
NSC 150555 Afungin 0.00662388971299133 0.5261797
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.00662388971299133 0.33585716
NSC 255105 GELDANAMYCIN ANALOG 0.00662388971299133 0.31851756
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.00662388971299133 0.26576688
Total:131  Current:34    [First] [Prev] [Next] [Last]